Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how
Authors:
Open Access
- 1 June 2022
- journal article
- review article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 22 (3) , 315-325
Abstract
Type 2 diabetes (T2D) is a chronic metabolic disease characterized by hyperglycemia due to insulin resistance. Mounting evidence has correlated T2D to alterations in the composition of gut microbiota. Accordingly, targeting the gut microbiota has become an emerging strategy for T2D management. The aim of this article is to get a better insight into the rationale for targeting gut microbiota in T2D treatment. Thus, we herein reviewed the change of gut microbiota composition in T2D, factors shaping gut microbiota, and potential mechanisms behind the contribution of gut microbiota to T2D pathogenesis. At present, it has become possible to use intestinal microorganism capsules, bacteria liquid, and other preparations to carry out fecal microbiota transplantation for the treatment and intervention of T2D with insulin resistance and immune-mediated type 1 diabetes (T1D).Keywords
This publication has 100 references indexed in Scilit:
- Diversity, stability and resilience of the human gut microbiotaNature, 2012
- Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatmentEMBO Molecular Medicine, 2011
- Bile Acid Metabolism and the Pathogenesis of Type 2 DiabetesCurrent Diabetes Reports, 2011
- Gut Microbiota in Health and DiseasePhysiological Reviews, 2010
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic AdultsPLOS ONE, 2010
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- The gut flora as a forgotten organEMBO Reports, 2006
- Two Routes of Metabolic Cross-Feeding betweenBifidobacterium adolescentisand Butyrate-Producing Anaerobes from the Human GutApplied and Environmental Microbiology, 2006
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001